References
- 1RozeE, LangAE, VidailhetM Myoclonus-dystonia: classification, phenomenology, pathogenesis, and treatment. Curr Opin Neurol 2018;31(4):484–490. doi: 10.1097/WCO.000000000000057729952836
- 2KoukouniV, ValenteEM, CordivariC, BhatiaKP, QuinnNP Unusual familial presentation of epsilon-sarcoglycan gene mutation with falls and writer’s cramp. Mov Disord 2008;23:1913–1915. doi: 10.1002/mds.2193518702114
- 3RaymondD, Saunders-PullmanR, de Carvalho AguiarP, SchuleB, KockN, FriedmanJ, et al. Phenotypic spectrum and sex effects in 11 myoclonus-dystonia families with epsilon-sarcoglycan mutations. Mov Disord 2008;23(4):588–592. doi: 10.1002/mds.2178518175340
- 4PeallKJ, KurianMA, WardleM, WaiteAJ, HedderlyT, LinJP, et al. SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype. J Neurol 2014;261(12):2296–2304. doi: 10.1007/s00415-014-7488-325209853
- 5RozeE, ApartisE, ClotF, DorisonN, ThoboisS, Guyant-MarechalL, et al. Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations. Neurology 2008;70(13):1010–1016. doi: 10.1212/01.wnl.0000297516.98574.c018362280
- 6KosutzkaZ, TischS, BonnetC, RuizM, HainqueE, WelterML, et al. Long-term GPi-DBS improves motor features in myoclonus-dystonia and enhances social adjustment. Mov Disord 2019;34(1):87–94. doi: 10.1002/mds.2747430302819
- 7GrünewaldA, DjarmatiA, Lohmann-HedrichK, FarrellK, ZellerJA, AllertN, et al. Myoclonus-dystonia: significance of large SGCE deletions. Hum Mutat 2008;29(2):331–332. doi: 10.1002/humu.9521
- 8WeissbachA, WernerE, BallyJF, TuncS, LönsS, TimmannD, et al. Alcohol improves cerebellar learning deficit in myoclonus-dystonia: a clinical and electrophysiological investigation. Ann Neurol 2017;82(4):543–553. doi: 10.1002/ana.2503528869676
- 9GranthamHJ, GoldsmithP Adult-onset alcohol suppresible cervical dystonia: a case report. Mov Disord Clin Pract 2014;2(1):102–103. doi: 10.1002/mdc3.1209830363810
- 10NardocciN, ZoraidaG, BarzaghiC, ZibordiF, CianoC, GhezziD, et al. Myoclonus-dystonia syndrome: clinical presentation, disease course, and genetic features in 11 families. Mov Disord 2008;23(1):28–34. doi: 10.1002/mds.2171517853490
- 11KleinC, SchillingK, Saunders-PullmanRJ, GarrelsJ, BreakefieldXO, BrinMF, et al. A major locus for myoclonus-dystonia maps to chromosome 7q in eight families. Am J Hum Genet 2000;67(5):1314–1319. doi: 10.1086/32119311022010
- 12Tezenas du MontcelS, ClotF, VidailhetM, RozeE, DamierP, JedynakCP, et al. Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes. J Med Genet 2006;43(5):394–400. doi: 10.1136/jmg.2005.03678016227522
- 13ValenteEM, EdwardsMJ, MirP, DiGiorgioA, SalviS, DavisM, et al. The epsilon-sarcoglycan gene in myoclonic syndromes. Neurology 2005;64(4):737–739. doi: 10.1212/01.WNL.0000151979.68010.9B15728306
- 14AsmusF, GasserT Inherited myoclonus-dystonia. Adv Neurol 2004;94:113–119.14509663